Ceruloplasmin
Cp · Serum Ceruloplasmin · Copper OxidaseReference range, optimal functional medicine levels, and why ceruloplasmin is simultaneously a copper transport protein, an acute-phase inflammatory reactant, a ferroxidase enzyme essential for iron metabolism, and a marker of both copper excess and Wilson's disease copper deficiency.
Category: Longevity & Aging | Also known as: Cp, Serum Ceruloplasmin, Copper Oxidase, Ferroxidase
1. What This Test Measures
Ceruloplasmin is a copper-containing alpha-2 glycoprotein synthesized by the liver that serves as the primary copper transport protein in the bloodstream, carrying approximately 90% of serum copper. It functions enzymatically as a ferroxidase, oxidizing ferrous iron (Fe2+) to ferric iron (Fe3+) for loading onto transferrin and transport to bone marrow. Ceruloplasmin is also a positive acute-phase reactant elevated by IL-6 during inflammation, and its measurement is essential for Wilson's disease screening, copper status assessment, and understanding the copper-iron metabolic interface.
2. Optimal Range and Clinical Thresholds
| Ceruloplasmin | Interpretation |
|---|---|
| Below 10 mg/dL | Very low: Wilson's disease screening threshold; evaluate with serum copper and 24-hr urine copper |
| 10 to 18 mg/dL | Low: copper deficiency, protein malnutrition, nephrotic syndrome, or aceruloplasminemia |
| 18 to 30 mg/dL | Normal to optimal |
| 30 to 36 mg/dL | Upper normal: borderline; evaluate for acute inflammation (check hs-CRP) or estrogen effect |
| Above 36 mg/dL | Elevated: acute phase response (infection, inflammation, autoimmunity) or estrogen effect |
Ceruloplasmin is markedly elevated during pregnancy (2-fold above baseline) and by estrogen-containing medications (oral contraceptives and HRT). Always interpret alongside hs-CRP to determine whether elevation reflects true copper metabolism changes or acute-phase inflammatory upregulation.
3. Ceruloplasmin and Wilson's Disease Screening
Low ceruloplasmin (below 20 mg/dL, particularly below 10 mg/dL) in a young adult with liver disease, neurological symptoms, or psychiatric symptoms should trigger Wilson's disease evaluation. Wilson's disease (ATP7B gene mutations) causes copper accumulation in liver, brain, corneas (Kayser-Fleischer rings), and kidneys. The diagnostic evaluation includes: ceruloplasmin (below 20 mg/dL in 85% of patients), serum copper (elevated free copper fraction), 24-hour urine copper (above 100 mcg in symptomatic patients), slit-lamp examination for Kayser-Fleischer rings, and liver biopsy copper quantification in uncertain cases.
4. The Ceruloplasmin-Iron Connection
- Ferroxidase function: ceruloplasmin oxidizes Fe2+ to Fe3+ at the surface of cells exporting iron (hepatocytes, macrophages, enterocytes); without this oxidation, iron cannot be loaded onto transferrin and cannot enter the circulation
- Aceruloplasminemia: the rare genetic absence of ceruloplasmin function causes iron accumulation in the brain, liver, and pancreas with normal or elevated serum ferritin and normal transferrin saturation; ceruloplasmin is required to export iron from storage
- Copper deficiency anemia: copper deficiency reduces ceruloplasmin ferroxidase activity, trapping iron in cells and producing a microcytic or normocytic anemia that does not respond to iron supplementation; this anemia is indistinguishable from iron deficiency on standard testing without ceruloplasmin and copper measurement
- Clinical implication: patients with anemia not responding to iron supplementation should have ceruloplasmin, serum copper, and zinc measured to rule out copper deficiency as the driver of functional iron deficiency
5. Related Lab Tests
6. Clinical Perspective
Ceruloplasmin is the marker that connects the copper and iron stories in a single measurement, and it is clinically essential in two very different contexts. The first is Wilson's disease: a young patient with unexplained liver disease, neuropsychiatric symptoms, or Kayser-Fleischer rings and ceruloplasmin below 10 mg/dL is Wilson's disease until proven otherwise, and the stakes of missing it are irreversible liver and neurological damage. The second context is the patient with anemia that is not responding to iron supplementation: when ceruloplasmin and copper are low alongside low serum iron and normal or low ferritin, the mechanism is copper deficiency impairing ferroxidase function, not iron deficiency requiring more iron. These two clinical problems require completely opposite interventions, and ceruloplasmin is the test that routes the diagnosis correctly.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
7. Frequently Asked Questions
What is ceruloplasmin and what does it do?
Ceruloplasmin is the primary copper transport protein, carrying 90% of serum copper. It functions enzymatically as a ferroxidase, oxidizing ferrous iron to ferric iron for loading onto transferrin and transport to the bone marrow. Without ceruloplasmin ferroxidase activity, iron cannot exit storage cells efficiently, causing functional iron deficiency anemia despite adequate iron stores.
What does low ceruloplasmin indicate?
Ceruloplasmin below 10 mg/dL is the primary screening signal for Wilson's disease (genetic copper accumulation from ATP7B mutations) and should trigger comprehensive copper evaluation including 24-hour urine copper and slit-lamp examination. Other causes of low ceruloplasmin include copper deficiency, severe protein malnutrition, nephrotic syndrome (urinary ceruloplasmin loss), and aceruloplasminemia.
What does elevated ceruloplasmin indicate?
Elevated ceruloplasmin (above 36 mg/dL) most commonly reflects acute-phase inflammatory activation, since ceruloplasmin is a positive acute-phase reactant whose synthesis is strongly upregulated by IL-6 during inflammation, infection, and autoimmune disease. Estrogen markedly elevates ceruloplasmin; oral contraceptives and pregnancy can raise levels 2-fold. Always check hs-CRP to determine whether elevation reflects inflammation versus true copper metabolism changes.
Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Anemia not responding to iron supplementation may not be iron deficiency at all. Low ceruloplasmin and copper may be the missing diagnosis.
Ceruloplasmin connects copper transport to iron metabolism and Wilson's disease screening. Schedule a consultation for a comprehensive trace mineral and iron status evaluation.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.
